摘要
There have been great advancements in targeted nanodrug delivery systems for tumor therapy. Liposomes, polymeric nanoparticles, and inorganic nanoparticles are commonly employed as nanocarriers for drug delivery, and it has been found that arginine glycine aspartic acid (RGD) peptides and their derivatives can be used as ligands of integrin receptors to enhance the direct targeting ability. In this paper, we review the recent applications of RGD-modified liposomes, polymeric nanoparticles, and inorganic nanocarriers in cancer diagnosis and treatment, discuss the current challenges and prospects, and examine the progress made by the latest research on RGD peptide-modified nano delivery systems in cancer therapy. In recent years, RGD peptide-modified nanodrug delivery systems have been proven to have great potential in tumor therapy. Finally, we provide an overview of the current limitations and future directions of RGD peptide-modified nano-drug delivery systems for cancer therapy. This review aims to elucidate the contribution of RGD peptide-modified nanodrug delivery systems in the field of tumor therapy.
学科与关键词
- In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded NanoparticlesYun, Dan; Liu, Dengyuan; Liu, Jinlin; Feng, Yanyi; Chen, Hongyu; Chen, Simiao; Xie, Qingchun*Pharmaceutics, 2023, 15(11): 2644.
- iRGD修饰的阿霉素主动靶向脂质体的细胞毒与抗肿瘤效果评价赵波; 范俣辰; 王学清; 代文兵; 张强; 王杏林药学学报, 2013, (03): 417-422.
- NGR多肽修饰的脂质体及其抗肿瘤研究进展王咏; 陈军; 林爱华; 方芸中国中药杂志, 2013, (13): 2041-2045.
